Press Releases
Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma
FIBROSARC (NCT04650984) is a Phase III trial evaluating Onfekafusp alfa (L19TNF, also known as Fibromun) plus doxorubicin versus doxorubicin alone as front-line therapy for patients with advanced or metastatic Soft...
Read morePhilogen announces new publication in Nature Chemistry
The study was conducted by scientists at Philochem AG, the wholly owned Swiss subsidiary company of the Philogen group. The paper can be accessed on the Nature Chemistry website at...
Read morePhilochem will be attending the 10th World ADC Conference in London
Philochem will be attending the 10th World ADC Conference in London (United Kingdom) from March 2 to 5, 2020 10th World ADC London Dr. Samuele Cazzamalli will give a plenary lecture on: “Small...
Read morePhilogen announces publication in Chem (Cell Press) on novel affinity matured OncoFAP ligands
Philogen announces publication in Chem (Cell Press) on novel affinity matured OncoFAP ligands isolated from DNA-Encoded Chemical Libraries. The novel OncoFAP ligands show a prolonged residence time in Fibroblast Activation Protein (FAP)...
Read moreUpcoming Events
Philochem to attend the 23rd Human Proteome Organization World Congress as presenting authors on October 20-24, 2024 in Dresden, Germany)
Philochem will participate at the 23rd HUPO Congress in October, presenting two posters: Domenico Ravazza (3rd year Ph.D. student): Mass spectrometry as a quantitative methodology to assess the biodistribution of...
Read morePhilochem to attend as Lecturer to the Summer School in Pharmaceutical Analysis 2024 in Rimini on September 18-20, 2024
Dr. Ettore Gilardoni (Head of Mass Spectrometry) will participate as Lecturer to the Summer School in Pharmaceutical Analysis 2024 in Rimini with a presentation on “Analysis of “High‐risk” host cell...
Read morePhilogen to attend the TIDES Europe 2022 in Vienna, Austria (16-18 November)
Philogen will attend the TIDES Europe in Vienna in November 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture entitled “Non-internalizing Small Molecule-Drug Conjugates and...
Read morePast Events
Philochem to attend the 72nd ASMS Conference on Mass Spectrometry and Allied Topics in Anaheim on June 2-6, 2024
Dr. Ettore Gilardoni (Head of Mass Spectrometry) will attend the 72nd ASMS conference in Anaheim (2-6 June 2024) and present a poster entitled: “Mass Spectrometry evaluation of glycosylation variants and...
Read morePhilochem to attend the 71st American Society for Mass Spectrometry Conference on June 4-8, 2023
Dr. Ettore Gilardoni (Head of Bio-MS) will present a poster entitled: Proteomic analysis reveals insights into the mechanism of the Intra-cork approach for increasing therapeutic window of immunocytokines Domenico Ravazza,...
Read morePhilogen to attend AACR Annual Meeting in Orlando on April 14-18, 2023
Prof. Dr. Dario Neri (CEO and CSO), Dr. Covelli (CMO), Dr. Dakhel, Dr. De Luca, Dr. Cazzamalli, Dr. Galbiati, Dr. Puca, Sara Puglioli. Matilde Bocci, Giulia Rotta, Eleonora Prodi and...
Read more